# Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain

> **NCT02728037** · PHASE3 · TERMINATED · sponsor: **Queen's University** · enrollment: 38 (actual)

## Conditions studied

- Pelvic Pain

## Interventions

- **PROCEDURE:** Magnesium-Based Injection Formulation
- **PROCEDURE:** Lidocaine-Only Injection Formulation
- **DRUG:** lidocaine
- **DRUG:** magnesium sulfate, bicarbonate, dextrose.

## Key facts

- **NCT ID:** NCT02728037
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2020-03
- **Final completion:** 2020-04
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Low Enrollment, Adoption of investigational treatment into standard practice at our center.
- **Last updated:** 2023-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02728037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02728037, "Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02728037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*